Lipopolysaccharide induced lung inflammation is inhibited by Lonicera japonica

Molecular and Cellular Toxicology

Volumn 7, Issue 1, 2011, Pages 87-93

  Lee, Hyojung ^a   Lee, Dugjae ^a   Kim, Youngeun ^a   Lee, Gihyun ^a   Kim, Soo Jeong ^a   Jung, Sungki ^a   Jung, Heejae ^a   Bae, Hyunsu ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Chronic obstructive pulmonary disease; Herbal medicine; Lonicera japonica; TNF

Indexed keywords

EID: 79960108602     PISSN: 1738642X     EISSN: 20928467     Source Type: Journal    
DOI: 10.1007/s13273-011-0012-2     Document Type: Article

References (26)

1. Barnes, P. J. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 8:183-192 (2008). (Pubitemid 351323287)
2. Yoshida, T. & Tuder, R. M. Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease. Physiol Rev 87:1047-1082 (2007). (Pubitemid 47084676)
3. Keatings, V. M. et al. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 155:542-548 (1997). (Pubitemid 27085799)
4. Barnes, P. J. Novel approaches and targets for treatment of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160:S72-79 (1999).
5. Loppow, D. et al. In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation. Respir Med 95:115-121 (2001). (Pubitemid 32624442)
6. Barnes, P. J. & Stockley, R. A. COPD: current therapeutic interventions and future approaches. Eur Respir J 25:1084-1106 (2005). (Pubitemid 40823786)
7. Calixto, J. B. et al. Anti-inflammatory compounds of plant origin. Part II. modulation of pro-inflammatory cytokines, chemokines and adhesion molecules. Planta Med 70:93-103 (2004). (Pubitemid 38299768)
8. Guo, R., Pittler, M. H. & Ernst, E. Herbal medicines for the treatment of COPD: a systematic review. Eur Respir J 28:330-338 (2006). (Pubitemid 44914232)
9. Park, E. et al. Anti-inflammatory activity of herbal medicines: inhibition of nitric oxide production and tumor necrosis factor-alpha secretion in an activated macrophage-like cell line. Am J Chin Med 33:415-424 (2005). (Pubitemid 40909139)
10. Xagorari, A. et al. Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages. J Pharmacol Exp Ther 296:181-187 (2001). (Pubitemid 32015077)
11. Hsueh, W. et al. The role of the complement system in shock and tissue injury induced by tumour necrosis factor and endotoxin. Immunology 70:309-314 (1990). (Pubitemid 20212240)
12. Rogers, D. F. Mucus pathophysiology in COPD: differences to asthma, and pharmacotherapy. Monaldi Arch Chest Dis 55:324-332 (2000).
13. Barnes, P. J. Mechanisms in COPD: differences from asthma. Chest 117:10S-14S (2000). (Pubitemid 30111557)
14. Mannino, D. M. & Buist, A. S. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 370:765-773 (2007). (Pubitemid 47321908)
15. Siafakas, N. M. et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J 8:398-420 (1995).
16. George, J. et al. Use of complementary and alternative medicines by patients with chronic obstructive pulmonary disease. Med J Aust 181:248-251 (2004). (Pubitemid 39247882)
17. Puljic, R. et al. Lipopolysaccharide-induced lung inflammation is inhibited by neutralization of GM-CSF. Eur J Pharmacol 557:230-235 (2007). (Pubitemid 46201806)
18. Chung, K. F. Cytokines in chronic obstructive pulmonary disease. Eur Respir J Suppl 34:50s-59s (2001). (Pubitemid 34760609)
19. Mukhopadhyay, S., Hoidal, J. R. & Mukherjee, T. K. Role of TNFalpha in pulmonary pathophysiology. Respir Res 7:125 (2006).
20. Drost, E. M. & MacNee, W. Potential role of IL-8, platelet-activating factor and TNF-alpha in the sequestration of neutrophils in the lung: effects on neutrophil deformability, adhesion receptor expression, and chemotaxis. Eur J Immunol 32:393-403 (2002). (Pubitemid 34173331)
21. Chen, C. Y. et al. Luteolin suppresses inflammationassociated gene expression by blocking NF-kappaB and AP-1 activation pathway in mouse alveolar macrophages. Life Sci 81:1602-1614 (2007).
22. Faurschou, M. & Borregaard, N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect 5:1317-1327 (2003). (Pubitemid 37410245)
23. Lungarella, G. et al. The dual role of neutrophil elastase in lung destruction and repair. Int J Biochem Cell Biol 40:1287-1296 (2008).
24. Shapiro, S. D. et al. Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice. Am J Pathol 163:2329-2335 (2003). (Pubitemid 37466476)
25. Qian, Z. M. et al. Simultaneous qualitation and quantification of thirteen bioactive compounds in Flos lonicerae by high-performance liquid chromatography with diode array detector and mass spectrometry. Chem Pharm Bull (Tokyo) 55:1073-1076 (2007).
26. Myou, S. et al. Blockade of inflammation and airway hyperresponsiveness in immune-sensitized mice by dominant-negative phosphoinositide 3-kinase-TAT. J Exp Med 198:1573-1582 (2003). (Pubitemid 37467171)